Tsukuba, Japan

Hiroaki Okutsu

This inventor holds 6 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignee: Hisamitsu Pharmaceutical Company, Inc.. Active years: 2016-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroaki Okutsu. Retrieved from https://idiyas.com/inventor/hiroaki-okutsu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2016-2020

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Hiroaki Okutsu: Innovator in Pharmaceutical Patch Technology

Introduction

Hiroaki Okutsu is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of innovative patches for drug delivery. With a total of six patents to his name, Okutsu's work focuses on enhancing the efficacy and safety of transdermal drug administration.

Latest Patents

One of Okutsu's latest patents is a method for producing a patch that includes a support layer and an adhesive agent layer. This adhesive layer contains sodium diacetate, a pressure-sensitive adhesive base agent, and asenapine or a pharmaceutically acceptable salt thereof. The method involves generating sodium diacetate from sodium acetate in the presence of asenapine, ensuring that the content of asenapine in the adhesive layer ranges from 3.0 to 20 mg. When the patch is applied to the skin for 24 hours, the concentration of free asenapine is maintained within a specific range, demonstrating the patch's effectiveness in drug delivery.

Another notable patent involves a patch designed for administering asenapine, which also features a support layer and an adhesive agent layer. The adhesive base agent in this patch comprises various materials, including natural rubber and polyisobutylene, with a content range of 10 to 90% by mass. This innovation ensures that when the patch is in contact with the skin, it achieves a significant area under the curve (AUC) for free asenapine, indicating its potential for effective therapeutic outcomes.

Career Highlights

Hiroaki Okutsu is currently associated with Hisamitsu Pharmaceutical Company, Inc., where he continues to advance his research and development efforts. His work has been instrumental in creating effective transdermal delivery systems that improve patient compliance and therapeutic efficacy.

Collaborations

Okutsu has collaborated with notable colleagues, including Masayuki Suzuki and Takashi Yasukochi. Their combined expertise has contributed to the successful development of innovative pharmaceutical solutions.

Conclusion

Hiroaki Okutsu's contributions to the field of pharmaceutical technology, particularly in the development of transdermal patches, highlight his role as a leading inventor. His innovative approaches and collaborative efforts continue to pave the way for advancements in drug delivery systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…